144 related articles for article (PubMed ID: 38008745)
1. Effect of preoperative PI-RADS assessment on pathological outcomes in patients who underwent radical prostatectomy.
Peng Q; Xu L; Zhang G; Zhang D; Zhang J; Zhang X; Bai X; Chen L; Jin Z; Sun H
Cancer Imaging; 2023 Nov; 23(1):113. PubMed ID: 38008745
[TBL] [Abstract][Full Text] [Related]
2. Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy.
Patel U; Dasgupta P; Challacombe B; Cahill D; Brown C; Patel R; Kirby R
BJU Int; 2017 Jan; 119(1):82-90. PubMed ID: 27153933
[TBL] [Abstract][Full Text] [Related]
3. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Multiparametric Prostate Magnetic Resonance Imaging Structured Report Informs Risk for Positive Apical Surgical Margins During Radical Prostatectomy.
Costa DN; Meng X; Tverye A; Bagrodia A; Recchimuzzi DZ; Xi Y; Arraj P; Shah RB; Subramanian N; de Leon AD; Roehrborn CG; Rofsky NM; Chen H; Pedrosa I
J Comput Assist Tomogr; 2023 Jan-Feb 01; 47(1):38-44. PubMed ID: 35995580
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Visible Tumor (PI-RADS ≥ 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis.
Özkan A; Köseoğlu E; Kılıç M; Baydar DE; Sağlıcan Y; Balbay MD; Canda AE; Kordan Y; Kiremit MC; Çil B; Tuğcu V; Bakır B; Esen T
Clin Genitourin Cancer; 2022 Feb; 20(1):e61-e67. PubMed ID: 34750082
[TBL] [Abstract][Full Text] [Related]
6. Preoperative MRI-based estimation of risk for positive resection margin after radical prostatectomy in patients with prostate cancer: development and validation of a simple scoring system.
Park MY; Park KJ; Kim MH; Kim JK
Eur Radiol; 2021 Jul; 31(7):4898-4907. PubMed ID: 33386982
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.
Baboudjian M; Gondran-Tellier B; Touzani A; Martini A; Diamand R; Roche JB; Lacetera V; Beauval JB; Roumeguère T; Simone G; Benamran D; Fourcade A; Fiard G; van den Bergh RCN; Peltier A; Ploussard G
Eur Urol Oncol; 2023 Aug; 6(4):406-413. PubMed ID: 36280445
[TBL] [Abstract][Full Text] [Related]
8. Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.
Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ
Eur Radiol; 2016 Aug; 26(8):2502-9. PubMed ID: 26560721
[TBL] [Abstract][Full Text] [Related]
9. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
[TBL] [Abstract][Full Text] [Related]
10. Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy.
Fujimoto A; Sakamoto S; Horikoshi T; Zhao X; Yamada Y; Rii J; Takeuchi N; Imamura Y; Sazuka T; Matsusaka K; Ikeda JI; Ichikawa T
Sci Rep; 2023 Jun; 13(1):10079. PubMed ID: 37344491
[TBL] [Abstract][Full Text] [Related]
11. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
Faiena I; Salmasi A; Mendhiratta N; Markovic D; Ahuja P; Hsu W; Elashoff DA; Raman SS; Reiter RE
J Urol; 2019 Jan; 201(1):91-97. PubMed ID: 30577397
[TBL] [Abstract][Full Text] [Related]
12. [PI-RADS score of prostate multi-parametric magnetic resonance imaging predicts pathological features of prostate cancer: An imaging to whole-mount pathology matching study].
Gao J; Wang BJ; Zhang Q; Zhao XZ; Fu Y; Li DY; Wang W; Guo HQ
Zhonghua Nan Ke Xue; 2022 Mar; 28(3):217-222. PubMed ID: 37462959
[TBL] [Abstract][Full Text] [Related]
13. Pathological features of Prostate Imaging Reporting and Data System (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens.
Rahota RG; Diamand R; Malavaud B; Fiard G; Descotes JL; Peltier A; Beauval JB; Roumeguère T; Roumiguié M; Albisinni S; Ploussard G
BJU Int; 2022 May; 129(5):621-626. PubMed ID: 34358405
[TBL] [Abstract][Full Text] [Related]
14. PI-RADS v2 and periprostatic fat measured on multiparametric magnetic resonance imaging can predict upgrading in radical prostatectomy pathology amongst patients with biopsy Gleason score 3 + 3 prostate cancer.
Zhai L; Fan Y; Sun S; Wang H; Meng Y; Hu S; Wang X; Yu W; Jin J
Scand J Urol; 2018; 52(5-6):333-339. PubMed ID: 30895901
[TBL] [Abstract][Full Text] [Related]
15. [Correlation analysis between prostate imaging report and data system score and pathological results of prostate cancer].
Zhu LY; Ding XF; Huang TB; Luan Y; Guo CH; Xu YZ; Wang F
Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(34):2663-2668. PubMed ID: 32921014
[No Abstract] [Full Text] [Related]
16. Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical Prostatectomy.
Fukui Y; Yamada Y; Sakamoto S; Horikoshi T; Zhao X; Sato K; Nanba S; Kubota Y; Kanesaka M; Fujimoto A; Shibata H; Goto Y; Sazuka T; Imamura Y; Uno T; Ichikawa T
Anticancer Res; 2023 Dec; 43(12):5705-5712. PubMed ID: 38030183
[TBL] [Abstract][Full Text] [Related]
17. PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer.
Woo S; Kim SY; Lee J; Kim SH; Cho JY
Eur Radiol; 2016 Oct; 26(10):3580-7. PubMed ID: 26847042
[TBL] [Abstract][Full Text] [Related]
18. Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patients.
Alessi S; Pricolo P; Summers P; Femia M; Tagliabue E; Renne G; Bianchi R; Musi G; De Cobelli O; Jereczek-Fossa BA; Bellomi M; Petralia G
Eur Radiol; 2019 Oct; 29(10):5478-5487. PubMed ID: 30887199
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the relationship between PI-RADS scores and the pathological results of targeted biopsy based on MRI].
Wang YM; Shang JW; Dong L; Liang LH; Zhao RZ; Liang C; Wang SQ; Xia W; Cheng G; Hua LX
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):942-947. PubMed ID: 37968079
[No Abstract] [Full Text] [Related]
20. Preoperative MRI PI-RADS scores are associated with prostate cancer upstaging on surgical pathology.
Pockros B; Stensland KD; Parries M; Frankenberger E; Canes D; Moinzadeh A
Prostate; 2022 Feb; 82(3):352-358. PubMed ID: 34878175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]